These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9929105)

  • 1. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
    García-Manero G; Schuster SJ; Patrick H; Martinez J
    Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
    Dingli D; Utz JP; Krowka MJ; Oberg AL; Tefferi A
    Chest; 2001 Sep; 120(3):801-8. PubMed ID: 11555513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy.
    Wanless IR; Peterson P; Das A; Boitnott JK; Moore GW; Bernier V
    Hepatology; 1990 Nov; 12(5):1166-74. PubMed ID: 2227815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
    Kessler CM; Klein HG; Havlik RJ
    Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia].
    Haddad F; Anouti S; Maalouly G; Jammal M; Nemnoum R; Kettaneh A
    Rev Med Interne; 2009 Sep; 30(9):803-5. PubMed ID: 19674818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia.
    Marvin KS; Spellberg RD
    Chest; 1993 Feb; 103(2):642-4. PubMed ID: 8432180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac involvement in patients with myeloproliferative disorders.
    Reisner SA; Rinkevich D; Markiewicz W; Tatarsky I; Brenner B
    Am J Med; 1992 Nov; 93(5):498-504. PubMed ID: 1442851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular mural thrombus in a patient with thrombocytosis and agnogenic myeloid metaplasia.
    Baker KM; Hess CE; Ayers CR; Johns DW; Mentzer RM; Wellsons HA; Taylor GJ; Martin RP
    Arch Intern Med; 1981 Oct; 141(11):1527-9. PubMed ID: 7283566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial myeloproliferative syndrome.
    Pérez-Encinas M; Bello JL; Pérez-Crespo S; De Miguel R; Tome S
    Am J Hematol; 1994 Jul; 46(3):225-9. PubMed ID: 8192153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
    Martinez J; Shapiro SS; Holburn RR
    Blood; 1973 Jul; 42(1):35-46. PubMed ID: 4736876
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
    Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
    Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
    Stein BL; Williams DM; O'Keefe C; Rogers O; Ingersoll RG; Spivak JL; Verma A; Maciejewski JP; McDevitt MA; Moliterno AR
    Haematologica; 2011 Oct; 96(10):1462-9. PubMed ID: 21712540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension with massive megalosplenia: A case report.
    Yi T; Ma W; Qiu J; Ding W
    Medicine (Baltimore); 2019 Mar; 98(12):e14594. PubMed ID: 30896614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.
    Jindamai Y; Rattarittamrong E; Phrommintikul A; Yongsmith L; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
    Int J Hematol; 2020 Nov; 112(5):631-639. PubMed ID: 32700192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial.
    Gowin K; Jain T; Kosiorek H; Tibes R; Camoriano J; Palmer J; Mesa R
    Leuk Res; 2017 Mar; 54():73-77. PubMed ID: 28113109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.
    Brabrand M; Hansen KN; Laursen CB; Larsen TS; Vestergaard H; Abildgaard N
    Eur J Haematol; 2019 Mar; 102(3):227-234. PubMed ID: 30450659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS].
    KUNZ G
    Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic myeloproliferative diseases].
    Sréter L
    Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia.
    Hershko C; Polliack A
    Isr J Med Sci; 1971 Feb; 7(2):315-20. PubMed ID: 5560987
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES].
    STOBBE H
    Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.